Company: AEMD
Filing Date: 2025-06-26
Form Type: 10-K
Source: 0001683168-25-004780
Chunk: 796

Company: AETHLON MEDICAL INC
Filing Date: 2025-06-26
Form: 10-K
Item: Item 4
Chunk 796
---
 2025 and 2024, respectively 
     2,586  
     329 
  
    Additional paid-in capital 
     173,092,894  
     160,339,671 
  
    Accumulated other comprehensive loss 
     (17,133) 
     (6,940)
  
    Accumulated deficit 
     (167,954,817) 
     (154,566,728)

    TOTAL STOCKHOLDERS’ EQUITY 
     5,123,530  
     5,766,332 

    TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY 
    $7,359,534  
    $8,245,982 

See accompanying notes to the consolidated financial
statements.

 F-5 

AETHLON MEDICAL, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE
LOSS

    Years Ended March 31, 

    2025  
    2024 

    OPERATING COSTS AND EXPENSES 

    Professional fees 
     2,224,092  
     3,526,926 
  
    Payroll and related expenses 
     3,874,092  
     5,206,451 
  
    General and administrative 
     3,243,181  
     3,903,191 
  
    Total operating expenses 
     9,341,365  
     12,636,568 

    OPERATING LOSS 
     (9,341,365) 
     (12,636,568)

    OTHER EXPENSE (INCOME), NET 

    Interest income 
     (298,122) 
     (447,356)
  
    Other income 
     (324,450) 
     – 
  
    Interest expense 
     10,109  
     – 
  
    Other expense 
     4,659,188  
     18,962 
  
    Total other expense (income), net 
     4,046,725  
     (428,394)

    NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS 
     (13,388,089) 
     (12,208,174)

    Basic and diluted net loss per share attributable to common stockholders 
    $(8.58